Umlaut.bio is a startup based in Germany, 1 tracked investor.
Based in Germany, Umlaut.bio is a startup. Brouky records 1 investor associated with the company.
Umlaut.bio develops a platform for discovering and developing next-generation biologics. It uses computational biology and high-throughput experimental techniques to engineer proteins with enhanced therapeutic properties.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.